Alpha Teknova, Inc. PE Ratio
The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.
- Alpha Teknova, Inc. pe ratio for the quarter ending 2026-06-30 was -18.12, a change of -5.9 year-over-year.
- Alpha Teknova, Inc. pe ratio for the quarter ending 2026-03-31 was -8.93, a change of 2.98 year-over-year.
- Alpha Teknova, Inc. pe ratio for the quarter ending 2025-12-31 was -11.76, a change of 4.91 year-over-year.
- Alpha Teknova, Inc. pe ratio for the quarter ending 2025-09-30 was -18.15, a change of -10.01 year-over-year.
- Alpha Teknova, Inc. pe ratio for fiscal 2026 was -18.12.
- Alpha Teknova, Inc. pe ratio for fiscal 2025 was -11.76, a change of 4.91 from fiscal 2024.
- Alpha Teknova, Inc. pe ratio for fiscal 2024 was -16.67, a change of -12.54 from fiscal 2023.
- Alpha Teknova, Inc. pe ratio for fiscal 2023 was -4.14, a change of -0.79 from fiscal 2022.
- Available history
- 2021-06-30 to 2026-06-30
- Data captured
Historical PE Ratio
Annual PE Ratio
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |